Benzinga | Jul 29, 2021 06:06AM EDT

West Pharmaceutical Servs Q2 Adj. EPS $2.46 Beats $1.74 Estimate, Sales $723.60M Beat $669.38M Estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.46 per share which beat the analyst consensus estimate of $1.74 by 41.38 percent. This is a 96.8 percent increase over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $723.60 million which beat the analyst consensus estimate of $669.38 million by 8.10 percent. This is a 37.25 percent increase over sales of $527.20 million the same period last year.